Matches in SemOpenAlex for { <https://semopenalex.org/work/W2021303519> ?p ?o ?g. }
- W2021303519 endingPage "81" @default.
- W2021303519 startingPage "73" @default.
- W2021303519 abstract "The effects of a new antiallergic drug, quinotolast [sodium 5-(4-oxo-1-phenoxy-4H-quinolizine-3-carboxamido)tetrazolate monohydrate], were studied and compared with those of tranilast, amlexanox, pemirolast, repirinast and disodium cromoglycate (DSCG) in experimental allergic models. Quinotolast potently inhibited such type I allergic reactions as passive cutaneous anaphylaxis (PCA) and anaphylactic bronchoconstriction in rats by both intravenous and oral dosing. All of these effects were stronger than those of the reference drugs tested. Quinotolast inhibited histamine release from rat peritoneal cells, but it had no antagonistic effect on histamine-, serotonin-, platelet activating factor- or bradykinin-induced cutaneous reactions in rats. Moreover, it was clearly demonstrated that quinotolast and DSCG had a cross tachyphylaxis to inhibit PCA in rats, suggesting that these drugs, at least in part, share the same mechanism of action. Furthermore, quinotolast potently inhibited PCA in guinea pigs in which DSCG and other reference drugs showed poor inhibitory activity. Quinotolast also showed stronger inhibitory effects on histamine and peptide leukotrienes release from guinea pig lung fragments or mouse cultured mast cells than the other drugs tested. Thus, the effect of quinotolast on type I allergic reaction would seem to be based on an inhibition of mediator release from inflammatory cells including mast cells. The results suggest that quinotolast will be beneficial in the treatment of type I allergy-related diseases." @default.
- W2021303519 created "2016-06-24" @default.
- W2021303519 creator A5013118244 @default.
- W2021303519 creator A5013809362 @default.
- W2021303519 creator A5017075519 @default.
- W2021303519 creator A5032457479 @default.
- W2021303519 creator A5044071858 @default.
- W2021303519 creator A5052540989 @default.
- W2021303519 creator A5060923113 @default.
- W2021303519 creator A5062272819 @default.
- W2021303519 creator A5063612981 @default.
- W2021303519 creator A5070805669 @default.
- W2021303519 date "1993-01-01" @default.
- W2021303519 modified "2023-10-16" @default.
- W2021303519 title "Effects of Quinotolast, a New Orally Active Antiallergic Drug, on Experimental Allergic Models" @default.
- W2021303519 cites W102696797 @default.
- W2021303519 cites W143538806 @default.
- W2021303519 cites W1966402132 @default.
- W2021303519 cites W1966866092 @default.
- W2021303519 cites W1977406435 @default.
- W2021303519 cites W1981567893 @default.
- W2021303519 cites W1982219490 @default.
- W2021303519 cites W1984347073 @default.
- W2021303519 cites W1984719540 @default.
- W2021303519 cites W1992885987 @default.
- W2021303519 cites W1995113794 @default.
- W2021303519 cites W2014802054 @default.
- W2021303519 cites W2021059398 @default.
- W2021303519 cites W2026360768 @default.
- W2021303519 cites W2045705228 @default.
- W2021303519 cites W2048995438 @default.
- W2021303519 cites W2050123939 @default.
- W2021303519 cites W2055484555 @default.
- W2021303519 cites W2069927844 @default.
- W2021303519 cites W2082192343 @default.
- W2021303519 cites W2088465869 @default.
- W2021303519 cites W2410011135 @default.
- W2021303519 cites W4247723168 @default.
- W2021303519 doi "https://doi.org/10.1254/jjp.63.73" @default.
- W2021303519 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7505860" @default.
- W2021303519 hasPublicationYear "1993" @default.
- W2021303519 type Work @default.
- W2021303519 sameAs 2021303519 @default.
- W2021303519 citedByCount "7" @default.
- W2021303519 countsByYear W20213035192012 @default.
- W2021303519 countsByYear W20213035192016 @default.
- W2021303519 countsByYear W20213035192020 @default.
- W2021303519 countsByYear W20213035192023 @default.
- W2021303519 crossrefType "journal-article" @default.
- W2021303519 hasAuthorship W2021303519A5013118244 @default.
- W2021303519 hasAuthorship W2021303519A5013809362 @default.
- W2021303519 hasAuthorship W2021303519A5017075519 @default.
- W2021303519 hasAuthorship W2021303519A5032457479 @default.
- W2021303519 hasAuthorship W2021303519A5044071858 @default.
- W2021303519 hasAuthorship W2021303519A5052540989 @default.
- W2021303519 hasAuthorship W2021303519A5060923113 @default.
- W2021303519 hasAuthorship W2021303519A5062272819 @default.
- W2021303519 hasAuthorship W2021303519A5063612981 @default.
- W2021303519 hasAuthorship W2021303519A5070805669 @default.
- W2021303519 hasBestOaLocation W20213035191 @default.
- W2021303519 hasConcept C1122143 @default.
- W2021303519 hasConcept C126322002 @default.
- W2021303519 hasConcept C168481208 @default.
- W2021303519 hasConcept C170493617 @default.
- W2021303519 hasConcept C185592680 @default.
- W2021303519 hasConcept C203014093 @default.
- W2021303519 hasConcept C207480886 @default.
- W2021303519 hasConcept C2775933838 @default.
- W2021303519 hasConcept C2776042228 @default.
- W2021303519 hasConcept C2778815084 @default.
- W2021303519 hasConcept C2779020240 @default.
- W2021303519 hasConcept C2779726688 @default.
- W2021303519 hasConcept C2780035454 @default.
- W2021303519 hasConcept C2780269026 @default.
- W2021303519 hasConcept C2780769369 @default.
- W2021303519 hasConcept C2781082844 @default.
- W2021303519 hasConcept C2911192292 @default.
- W2021303519 hasConcept C49802076 @default.
- W2021303519 hasConcept C55493867 @default.
- W2021303519 hasConcept C71924100 @default.
- W2021303519 hasConcept C98274493 @default.
- W2021303519 hasConceptScore W2021303519C1122143 @default.
- W2021303519 hasConceptScore W2021303519C126322002 @default.
- W2021303519 hasConceptScore W2021303519C168481208 @default.
- W2021303519 hasConceptScore W2021303519C170493617 @default.
- W2021303519 hasConceptScore W2021303519C185592680 @default.
- W2021303519 hasConceptScore W2021303519C203014093 @default.
- W2021303519 hasConceptScore W2021303519C207480886 @default.
- W2021303519 hasConceptScore W2021303519C2775933838 @default.
- W2021303519 hasConceptScore W2021303519C2776042228 @default.
- W2021303519 hasConceptScore W2021303519C2778815084 @default.
- W2021303519 hasConceptScore W2021303519C2779020240 @default.
- W2021303519 hasConceptScore W2021303519C2779726688 @default.
- W2021303519 hasConceptScore W2021303519C2780035454 @default.
- W2021303519 hasConceptScore W2021303519C2780269026 @default.
- W2021303519 hasConceptScore W2021303519C2780769369 @default.
- W2021303519 hasConceptScore W2021303519C2781082844 @default.
- W2021303519 hasConceptScore W2021303519C2911192292 @default.